Breaking News Instant updates and real-time market news.

SRPT

Sarepta

$34.26

-2.46 (-6.70%)

, UNH

UnitedHealth

$160.54

2.22 (1.40%)

12:36
12/01/16
12/01
12:36
12/01/16
12:36

Sarepta DMD drug still likely to be covered by UnitedHealth, says RBC Capital

RBC Capital analyst Simos Simeonidis said some language in UnitedHealthcare's (UNH) Commercial Drug Policy for Sarepta's (SRPT) Exondys 51 may have "spooked" investors, but he continues to believe that the DMD drug will end up being covered by the insurer. The analyst, who would be a buyer of Sarepta amid this weakness, keeps an Outperform rating on the stock.

SRPT

Sarepta

$34.26

-2.46 (-6.70%)

UNH

UnitedHealth

$160.54

2.22 (1.40%)

SRPT Sarepta
$34.26

-2.46 (-6.70%)

10/27/16
FBCO
10/27/16
NO CHANGE
Target $68
FBCO
Outperform
Sarepta reimbursement concerns overdone, says Credit Suisse
Credit Suisse analyst Alethia Young believes Sarepta Exondys 51 reimbursement concerns are "quite overdone" and notes payer negotiation is inline with what the company has seen in other rare disease drugs launch. Young rates Sarepta an Outperform with a $68 price target.
10/27/16
WEDB
10/27/16
NO CHANGE
Target $72
WEDB
Outperform
Sarepta selloff overdone, says Wedbush
Wedbush analyst Heather Behanna said the selloff in Sarepta is overdone and recommends shares ahead of the Exondys 51 launch update in January. The analyst has an Outperform rating and a $72 price target on Sarepta shares.
11/11/16
LEER
11/11/16
NO CHANGE
Target $55
LEER
Market Perform
Sarepta Exondys 51 launch expectations seem too high for 2017, says Leerink
Leerink analyst Joseph Schwartz believes Sarepta Exondys 51 launch expectations may be too high for 2017. While nothing that a true Duchenne muscular dystrophy prevalence remains unknown, the analyst says that a "start form" number of about 200 patients would need to be provided in early January in order for investors to be confident in 2017 consensus sales estimates of $215M. Additionally, Schwartz points out that based on the price of Exondys 51 per vial, it currently appears that management has underestimated the true price of the drug which they will realize.
11/29/16
BARD
11/29/16
NO CHANGE
Target $102
BARD
Outperform
Baird sees strong launch for Sarepta after surveying neurologists
After his firm surveyed 30 neurologists treating at least ten Duchenne muscular dystrophy patients and at least five suspected/confirmed patients amenable to exon-51 skipping, Baird analyst Brian Skorney believes Sarepta Therapeutics' Exondys 51 is positioned for a strong launch. In a research note earlier today, Skorney said that most of the 30 doctors surveyed seem convinced of the drug's efficacy, and plan to start prescribing the drug in the next year. The drug's consensus sales estimate for its first quarter on the market of $7.1M may be understating sales, Skorney wrote. The analyst continues to expect $11M of Exondys 51 sales in Q4. He has an Outperform rating on shares of Sarepta with a $102 price target. The stock is up 34c, or 1%, to $36.62 in morning trading.
UNH UnitedHealth
$160.54

2.22 (1.40%)

11/30/16
OPCO
11/30/16
NO CHANGE
Target $171
OPCO
Outperform
UnitedHealth price target raised to $171 from $161 at Oppenheimer
Oppenheimer analyst Michael Wiederhorn raised his price target for UnitedHealth to $171 from $161 on "strong" 2017 outlook buoyed by robust Medicare Advantage growth. The analyst believes the business is performing well, and could benefit from the changes in Washington given the GOP bias toward managed care. Wiederhorn reiterates an Outperform rating on the shares and says he would continue to be a buyer of the blue-chip name.
11/30/16
UBSW
11/30/16
NO CHANGE
Target $193
UBSW
Buy
UnitedHealth price target raised to $193 from $180 at UBS
UBS analyst A.J. Rice raised his price target on UnitedHealth to $193 from $180 following its very positive investor day. The company said they see strong growth driven by both group and individual markets while controlling their commercial medical cost trend, noted Rice, who reiterated his Buy rating on UnitedHealth shares.
11/30/16
COWN
11/30/16
NO CHANGE
Target $175
COWN
Outperform
UnitedHealth price target raised to $175 from $150 at Cowen
Cowen analyst Christine Arnold raised her price target on UnitedHealth to $175 from $150 reflecting the company's guidance provided at its analyst day.The analyst said UnitedHealth remains a top pick for 2017 as it has an abundance of tailwinds and minimal company-specific headwinds. Arnold reiterated her Outperform rating on UnitedHealth shares.
11/30/16
SBSH
11/30/16
NO CHANGE
Target $178
SBSH
Buy
UnitedHealth price target raised to $178 after analyst day at Citi
Citi analyst Ralph Giacobbe said UnitedHealth's "upbeat tone" at its investor day matched the company's "impressive" 2017 guidance, saying the company remains in an enviable position of having size, scale, and infrastructure to invest while expanding its reach via Optum. Giacobbe raised his price target on UnitedHealth shares to $178 from $164 and keeps a Buy rating on the stock.

TODAY'S FREE FLY STORIES

BHI

Baker Hughes

$65.40

1.4 (2.19%)

13:02
12/02/16
12/02
13:02
12/02/16
13:02
Hot Stocks
Baker Hughes reports U.S. rig count up 4 to 597 rigs »

Baker Hughes reports the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

DAL

Delta Air Lines

$48.38

0.61 (1.28%)

12:56
12/02/16
12/02
12:56
12/02/16
12:56
Hot Stocks
Ned Walker to return to Delta as chief communications officer »

John "Ned"…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBI

CB&I

$32.06

-1.7901 (-5.29%)

12:55
12/02/16
12/02
12:55
12/02/16
12:55
Options
CB&I put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MGM

MGM Resorts

$28.99

0.465 (1.63%)

12:55
12/02/16
12/02
12:55
12/02/16
12:55
Conference/Events
MGM Resorts participates in a luncheon meeting hosted by the National Press Club »

James Murren, Chairman…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Dec

VASC

Vascular Solutions

12:48
12/02/16
12/02
12:48
12/02/16
12:48
Downgrade
Vascular Solutions rating change  »

Vascular Solutions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:45
12/02/16
12/02
12:45
12/02/16
12:45
General news
Breaking General news story  »

Week of 12/2 Baker-Hughes…

NUS

Nu Skin

$50.75

0.52 (1.04%)

12:44
12/02/16
12/02
12:44
12/02/16
12:44
Conference/Events
Nu Skin to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 09

    Jan

SPY

SPDR S&P 500 ETF Trust

$219.77

0.1999 (0.09%)

, IVV

iShares Core S&P 500

$221.02

0.29 (0.13%)

12:41
12/02/16
12/02
12:41
12/02/16
12:41
Technical Analysis
On The Fly: ETF fund flow highlights »

For the week total flows…

SPY

SPDR S&P 500 ETF Trust

$219.77

0.1999 (0.09%)

IVV

iShares Core S&P 500

$221.02

0.29 (0.13%)

XOP

SPDR Oil Exploration and Production Fund

$41.98

-0.075 (-0.18%)

FXR

First Trust Industrials/Producer Durables AlphaDEX Fund

$33.03

0.0144 (0.04%)

GLD

SPDR Gold Trust

$112.20

0.6635 (0.59%)

IAU

iShares Gold Trust

$11.34

0.07 (0.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PBIB

Porter Bancorp

12:40
12/02/16
12/02
12:40
12/02/16
12:40
Hot Stocks
Breaking Hot Stocks news story on Porter Bancorp »

Porter Bancorp trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALIOF

Actelion

$190.80

-5.45 (-2.78%)

, JNJ

Johnson & Johnson

$111.93

0.55 (0.49%)

12:34
12/02/16
12/02
12:34
12/02/16
12:34
Periodicals
Actelion's silence speaks volumes to hedge funds, Reuters says »

Actelion's (ALIOF)…

ALIOF

Actelion

$190.80

-5.45 (-2.78%)

JNJ

Johnson & Johnson

$111.93

0.55 (0.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVCN

Neovasc

$0.51

0.0018 (0.35%)

, BSX

Boston Scientific

$20.33

0.235 (1.17%)

12:31
12/02/16
12/02
12:31
12/02/16
12:31
Recommendations
Neovasc, Boston Scientific analyst commentary  »

Neovasc's Boston…

NVCN

Neovasc

$0.51

0.0018 (0.35%)

BSX

Boston Scientific

$20.33

0.235 (1.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 12

    Dec

FE

FirstEnergy

$30.62

-0.37 (-1.19%)

12:30
12/02/16
12/02
12:30
12/02/16
12:30
Options
Flurry of activity in First Energy puts »

Flurry of activity in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBKC

IBERIABANK

$84.15

1.3 (1.57%)

12:26
12/02/16
12/02
12:26
12/02/16
12:26
Upgrade
IBERIABANK rating change  »

IBERIABANK upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Dec

12:20
12/02/16
12/02
12:20
12/02/16
12:20
General news
Treasury Option Action: and now some bullish call buying »

Treasury Option Action:…

PBIB

Porter Bancorp

12:16
12/02/16
12/02
12:16
12/02/16
12:16
Hot Stocks
Breaking Hot Stocks news story on Porter Bancorp »

Porter Bancorp says court…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

12:16
12/02/16
12/02
12:16
12/02/16
12:16
Technical Analysis
NYSE market internals summary »

Breadth is bullish across…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

12:16
12/02/16
12/02
12:16
12/02/16
12:16
Technical Analysis
NASDAQ market internals summary »

Volume is light for this…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:15
12/02/16
12/02
12:15
12/02/16
12:15
General news
Breaking General news story  »

Federal Reserve Gov.…

PBIB

Porter Bancorp

12:13
12/02/16
12/02
12:13
12/02/16
12:13
Hot Stocks
Porter Bancorp announces appellate court affirms ruling »

Porter Bancorp, parent…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBUX

Starbucks

$58.51

0.54 (0.93%)

, WDAY

Workday

$71.33

-10.275 (-12.59%)

12:12
12/02/16
12/02
12:12
12/02/16
12:12
General news
On The Fly: Top stock stories at midday »

Stocks opened with modest…

SBUX

Starbucks

$58.51

0.54 (0.93%)

WDAY

Workday

$71.33

-10.275 (-12.59%)

ULTA

Ulta Beauty

$257.41

-2.09 (-0.81%)

P

Pandora

$12.58

1.095 (9.54%)

SIRI

Sirius XM

$4.56

-0.015 (-0.33%)

BX

Blackstone

$25.82

-0.33 (-1.26%)

GM

General Motors

$35.75

-0.6802 (-1.87%)

JPM

JPMorgan

$81.22

-0.57 (-0.70%)

BLK

BlackRock

$372.34

-4.86 (-1.29%)

DIS

Disney

$98.47

-0.4661 (-0.47%)

WMT

Wal-Mart

$70.74

0.0662 (0.09%)

IBM

IBM

$159.48

-0.342 (-0.21%)

INFO

IHS Markit

$35.11

-0.83 (-2.31%)

ASNA

Ascena Retail

$5.83

-0.21 (-3.48%)

FIVE

Five Below

$39.88

0.52 (1.32%)

AMBA

Ambarella

$61.39

-0.13 (-0.21%)

SWHC

Smith & Wesson

$23.98

0.65 (2.79%)

ATI

Allegheny Technologies

$16.05

-1.71 (-9.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 06

    Dec

  • 07

    Dec

  • 07

    Dec

  • 07

    Dec

  • 08

    Dec

  • 08

    Dec

  • 13

    Dec

  • 13

    Dec

  • 14

    Dec

  • 09

    Jan

  • 09

    Jan

  • 10

    Jan

  • 13

    Jan

  • 28

    Feb

  • 14

    Jul

  • 12

    Oct

SOHO

Sotherly Hotels

$5.48

-0.01 (-0.18%)

12:10
12/02/16
12/02
12:10
12/02/16
12:10
Hot Stocks
Sotherly Hotels announces $10M stock repurchase program »

Sotherly Hotels announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FCAU

Fiat Chrysler

$7.65

-0.09 (-1.16%)

12:10
12/02/16
12/02
12:10
12/02/16
12:10
Options
Fiat Chrysler Dec 7 - 8 call spread at 64c, 4K on ISE »

Fiat Chrysler Dec 7 - 8…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jan

PBIB

Porter Bancorp

12:07
12/02/16
12/02
12:07
12/02/16
12:07
Hot Stocks
Breaking Hot Stocks news story on Porter Bancorp »

Porter Bancorp trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DB

Deutsche Bank

$15.80

-0.26 (-1.62%)

12:02
12/02/16
12/02
12:02
12/02/16
12:02
Periodicals
Deutsche Bank to cease some coverage for about 3,400 clients, WSJ says »

Deutsche Bank plans to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jan

OZM

Och-Ziff Capital

$3.14

0.18 (6.08%)

12:01
12/02/16
12/02
12:01
12/02/16
12:01
Hot Stocks
Och-Ziff Capital advances after AUM increased in November »

In a regulatory filing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.